$182 Million is the total value of Invus Financial Advisors, LLC's 8 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CPNG | Coupang Inccl a | $50,786,000 | +30.7% | 3,046,571 | 0.0% | 27.88% | +18.9% | |
| RCUS | Arcus Biosciences Inc | $42,172,000 | +3.2% | 1,612,077 | 0.0% | 23.15% | -6.2% | |
| NVCR | Novocure Ltd | $26,660,000 | +9.3% | 350,884 | 0.0% | 14.63% | -0.6% | |
| Nu Hldgs Ltd | $24,565,000 | +17.6% | 5,582,950 | 0.0% | 13.48% | +6.9% | ||
| OYST | Oyster Point Pharma Inc | $15,559,000 | +29.8% | 2,768,586 | 0.0% | 8.54% | +18.0% | |
| TBLA | Taboola.com Ltd | $14,154,000 | -28.5% | 7,819,690 | 0.0% | 7.77% | -35.0% | |
| IONQ Inc | $5,070,000 | +15.8% | 1,000,000 | 0.0% | 2.78% | +5.2% | ||
| ORIC | Oric Pharmaceuticals Inc | $3,224,000 | -28.6% | 1,007,575 | 0.0% | 1.77% | -35.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Arcus Biosciences Inc | 16 | Q3 2023 | 24.7% |
| Novocure Ltd | 16 | Q3 2023 | 25.4% |
| Oric Pharmaceuticals Inc | 14 | Q3 2023 | 14.3% |
| Oyster Point Pharma Inc | 13 | Q4 2022 | 44.5% |
| Coupang Inc | 11 | Q3 2023 | 51.6% |
| Taboola.com Ltd | 10 | Q3 2023 | 23.7% |
| Unity Biotechnology Inc | 9 | Q4 2021 | 8.0% |
| Yext Inc | 8 | Q3 2021 | 30.3% |
| IONQ Inc | 8 | Q3 2023 | 7.2% |
| Nu Hldgs Ltd | 6 | Q3 2023 | 25.4% |
View Invus Financial Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Invus Financial Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.